ArticleScientific reports2025
Utility of the joint index in newborn congenital heart disease screening.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Dual Role of Neonatal Pulse Oximetry Screening and Fetal Echocardiography in Congenital Heart Disease Detection Around the World.International journal of neonatal screening · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To examine the value of"joint index"in the early and rapid screening of congenital heart disease (CHD) in newborns. The study selected live-born neonates who were delivered in the Department of Obstetrics and Gynecology at Sichuan Provincial People's Hospital from January 1, 2023 to December 31, 2023. Cardiac auscultation and pulse oximetry were performed at 6 h to 72 h after birth. To further elucidate the diagnosis and to analyze and compare the value of cardiac murmur, pulse oximetry, and the combination of cardiac murmur and pulse oximetry for the early diagnosis of CHD, cardiac ultrasonography was performed on newborns with positive screening for either cardiac murmur or pulse oximetry. The value of heart murmur, pulse oximetry, and their combination was assessed in the early diagnosis of CHD. A total of 3037 newborns were screened following the inclusion and exclusion criteria. Of them, a total of 304 positive cases were included in the present study and were divided into 3 groups: 142 cases in the heart murmur group, 99 cases in the oxygen saturation group, and 304 cases in the combined group of those who were positive for both heart murmur and/or oxygen saturation. A total of 215 cases of CHD were diagnosed via cardiac ultrasound in screen-positive newborns, including 26 cases of severe CHD. The top three types of CHD were atrial septal defect (33.95%), ventricular septal defect (26.05%), and arterial duct failure (20.47%). The diagnostic sensitivity, accuracy, and negative predictive value of the combined group were 100%, 97.07%, and 100%, respectively. These values were significantly higher than those of the heart murmur group and the oxygen saturation group (P < 0.01), and the overall difference among the three groups in terms of the positive predictive value was not statistically significant (P > 0.05). However, in the two-by-two comparisons within the groups, the positive predictive value of the combined group was greater than that of the oxygen saturation group, and the difference was statistically significant (70.72% vs. 50.89%; P < 0.05). The specificity of the combined group was 96.85%, which was lower than that of the murmur and oxygenation groups (98.37% vs. 98.55%; P < 0.01). However, considering the detection of severe CHD, a total of 14 cases of severe CHD were detected in patients with positive cardiac murmur and oxygenation in the combined group (53.83%), which was significantly higher than that in the murmur group (11.54%) and oxygenation group (34.62%, P < 0.01). The newborns can be screened for CHD using heart murmur auscultation combined with pulse oximetry, which is a convenient, sensitive, and accurate method. It can be utilized as an important tool for early clinical screening for CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.